Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection

Mentzer AJ., O’Connor D., Bibi S., Chelysheva I., Clutterbuck EA., Demissie T., Dinesh T., Edwards NJ., Felle S., Feng S., Flaxman AL., Karp-Tatham E., Li G., Liu X., Marchevsky N., Godfrey L., Makinson R., Bull MB., Fowler J., Alamad B., Malinauskas T., Chong AY., Sanders K., Shaw RH., Voysey M., Cavey A., Minassian A., Stuart A., Khozoee B., Hanumunthadu B., Angus B., Smith CC., Turnbull I., Kwok J., Emary KRW., Cifuentes L., Ramasamy MN., Cicconi P., Finn A., McGregor AC., Collins AM., Smith A., Goodman AL., Green CA., Duncan CJA., Williams CJA., Ferreira DM., Turner DPJ., Thomson EC., Hill H., Pollock K., Toshner M., Lillie PJ., Heath P., Lazarus R., Sutherland RK., Payne RO., Faust SN., Darton T., Libri V., Anslow R., Provtsgaard-Morys S., Hart T., Beveridge A., Adlou S., Snape MD., Pollard AJ., Lambe T., Knight JC.

DOI

10.1038/s41591-022-02078-6

Type

Journal article

Journal

Nature Medicine

Publisher

Springer Science and Business Media LLC

Publication Date

13/10/2022

Permalink Original publication